The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatmentYongchang Zhang, Guo‐Hui Fu|Oncotarget|2015Cited by 21
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Hongbin Ji, Meiting Yue et al.|The Journal of Experimental Medicine|2024Cited by 21
Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancerLianxi Song, Yongchang Zhang, Liang Zeng et al.|Communications Medicine|2022Cited by 20
Sintilimab plus docetaxel as second-line therapy of advanced non-small cell lung cancer without targetable mutations: a phase II efficacy and biomarker studyYongchang Zhang, Nong Yang|BMC Cancer|2022Cited by 19
Expert consensus on treatment for stage III non‐small cell lung cancerYi‐Long Wu, Yun Fan, Ying Cheng et al.|Medicine Advances|2023Cited by 18